Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -11.34 | 44.02 |
| PEG Ratio (TTM) | -0.46 | 8.83 |
| P/S Ratio (TTM) | 0.87 | 16.00 |
| P/B Ratio (TTM) | 3.82 | 16.30 |
| P/FCF Ratio (TTM) | 19.37 | 49.01 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.45 |
| Price to 5YR AVG FCF Ratio | N/A | 57.62 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.50% | 12.54% |
| ROE (TTM) | -32.42% | 57.22% |
| Net Profit Margin (TTM) | -7.73% | 24.24% |
| ROIC 5YR AVG | N/A | -10.20% |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -28.23% | -13.46% | N/A |
| Revenue | 2.63% | -26.73% | N/A |
| Net Income | -42.10% | -14.61% | N/A |
| Cash Flow | 281.12% | 90.14% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.68 | 1.54 |
| Quick Ratio (TTM) | 0.68 | 1.52 |
| D/E Ratio (TTM) | 0.04 | 0.88 |
| Interest Coverage (TTM) | -71.00 | 55.80 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 11.38 |
| LTL to 5YR AVG FCF | N/A | 4.83 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.28% |